Dr. Josie Tenore and Paul Hinds were introduced by a mutual friend in 2017 and hadn't been going out long when she laid down the law: He had to get a physical. "I don't date people who don't take care ...
Cipla is introducing leuprolide acetate injection depot, 22.5 mg, which is the generic of AbbVie’s Lupron Depot. It is indicated for palliative treatment of advanced prostate cancer. Leuprolide ...
TAP Pharmaceutical Products will likely pay a fine of more than $840 million to settle federal allegations that it inflated the price of its "top-selling" prostate cancer drug Lupron Depot, the Boston ...
LUPRON DEPOT (leuprolide acetate for extended-release injectable suspension) is a hormonal medication first approved by Health Canada in 1989 for advanced prostate cancer, and later for various ...
AbbVie (ABBV) announced that a new 6-month 45mg Lupron Depot strength has received Health Canada approval for the treatment of advanced prostate cancer. Lupron Depot is now available in four dosing ...
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/cvwck3/lupron_depot) has announced the addition of GlobalData's new report ...
ABBOTT PARK, Ill. — The Food and Drug Administration has approved a new formulation of an injectable drug made by Abbott for prostate cancer. Abbott announced Monday the approval of a 45-mg, six-month ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback